Year archive

Nyxoah SA — 2025 filings

All 140 regulatory filings released by Nyxoah SA (NYXH) in 2025, sourced directly from the official regulator.

140 Filings

2025 Period

2025 filings (140)

Filing	Released	Lang
Major Shareholding Notification 2025 Major Shareholding Notification	2025-12-29	English
FORM 6-K Regulatory Filings	2025-12-19	English
ENGLISH_Nyxoah SA - Press release First Tranche Bonds (ENG) (final).pdf Capital/Financing Update	2025-12-18	English
FRENCH_Nyxoah SA - Press Release First Tranche Bonds (FR) (final).pdf Capital/Financing Update	2025-12-18	French
Project Neurone - EY Report (Convertible) (signed).pdf Capital/Financing Update	2025-12-18	French
Project Neurone - Special Board Report (Convertible) (ENG) (signed) (INCL T&C).pdf Capital/Financing Update	2025-12-18	English
Project Neurone - Special Board Report (Convertible) (FR) (signed) (INCL T&C).pdf Regulatory Filings	2025-12-18	French
FORM 6-K Regulatory Filings	2025-12-05	English
2025 12 02 PR Transparency notification (Robert Taub) (ENG).pdf Major Shareholding Notification	2025-12-02	English
2025 12 02 PR Transparency notification (Robert Taub) (FR).pdf Major Shareholding Notification	2025-12-02	French
Major Shareholding Notification 2025 Major Shareholding Notification	2025-11-24	English
2025 11 20 - Press release - Number of shares (ENG).pdf Major Shareholding Notification	2025-11-20	English
2025 11 20 - Press release - Number of shares (FR).pdf Major Shareholding Notification	2025-11-20	French
Project Neurone - Special Board Report (ENG) - FINAL.pdf Share Issue/Capital Change	2025-11-18	English
Project Neurone - Special Board Report (FR) - FINAL.pdf Share Issue/Capital Change	2025-11-18	French
424B5 Regulatory Filings	2025-11-17	English
FORM 6-K/A Regulatory Filings	2025-11-15	English
FORM 6-K Regulatory Filings	2025-11-14	English
FWP Regulatory Filings	2025-11-14	English
FORM 6-K Regulatory Filings	2025-11-14	English
FORM 6-K Regulatory Filings	2025-11-13	English
PIPE RDO Convertible - PR (ENG).pdf Capital/Financing Update	2025-11-13	English
PIPE RDO Convertible - PR (FR).pdf Capital/Financing Update	2025-11-13	French
Q3 2025 financial report Nyxoah (ENG) - Euronext (final).pdf Interim / Quarterly Report 9M 2025	2025-11-13	English
Q3 2025 financial report Nyxoah (FR) (final).pdf Interim / Quarterly Report 9M 2025	2025-11-13	French
Q3 Nyxoah Reports Third Quarter 2025 Financial and Operating Results.pdf Earnings Release Q3 2025	2025-11-13	English
Q3 Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025.pdf Interim / Quarterly Report Q3 2025	2025-11-13	French
2025 10 03 PR Transparency notification (Vestal Point) (ENG).pdf Major Shareholding Notification	2025-10-03	English
2025 10 03 PR Transparency notification (Vestal Point) (FR).pdf Major Shareholding Notification	2025-10-03	French
FORM 6-K Regulatory Filings	2025-09-24	English
FORM 6-K/A Regulatory Filings	2025-09-24	English
FORM 6-K Regulatory Filings	2025-09-23	English
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. Legal Proceedings Report	2025-09-15	English
FORM 6-K Regulatory Filings	2025-09-15	English
FORM 6-K Regulatory Filings	2025-09-08	English
2025 09 05 PR Transparency notifications 2025 09 (Cochlear) (ENG).pdf Major Shareholding Notification	2025-09-05	English
2025 09 05 PR Transparency notifications 2025 09 (Cochlear) (FR).pdf Major Shareholding Notification	2025-09-05	French
2025 08 29 - Press release - Number of shares (ENG).pdf Declaration of Voting Results & Voting Rights Announcements	2025-08-29	English
2025 08 29 - Press release - Number of shares (FR).pdf Declaration of Voting Results & Voting Rights Announcements	2025-08-29	French
6-K Regulatory Filings	2025-08-18	English
ENGLISH_Q2 2025 Earnings PR_FINAL.pdf Interim / Quarterly Report Q2 2025	2025-08-18	English
FRENCH_Q2 2025 Earnings PR_FINAL.pdf Interim / Quarterly Report Q2 2025	2025-08-18	French
Q2 2025 financial report (Euronext) (ENG) (final).pdf Interim / Quarterly Report H1 2025	2025-08-18	English
Q2 2025 financial report (Euronext) (FR) (final).pdf Interim / Quarterly Report H1 2025	2025-08-18	French
Nyxoah Reports Second Quarter Financial and Operating Results Earnings Release Q2 2025	2025-08-18	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-08-14	English
FORM 6-K Regulatory Filings	2025-08-11	English
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Earnings Release Q2 2025	2025-08-11	English
Nyxoah Receives Approval from FDA for Genio System for the Treatment of Obstructive Sleep Apnea Regulatory Filings	2025-08-08	English
ENGLISH_FDA APPROVAL PRESS RELEASE - FINAL.pdf Regulatory Filings	2025-08-08	English
FRENCH_FDA APPROVAL PRESS RELEASE - FINAL.pdf Regulatory Filings	2025-08-08	French
2025 07 29 - Press release - Number of shares (ENG).pdf Declaration of Voting Results & Voting Rights Announcements	2025-07-29	English
2025 07 29 - Press release - Number of shares (FR).pdf Declaration of Voting Results & Voting Rights Announcements	2025-07-29	French
FORM 6-K Regulatory Filings	2025-07-29	English
Nyxoahs DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine Legal Proceedings Report	2025-07-28	English
Nyxoah - Second ESM 2025 - Resolutions - ENG.pdf Declaration of Voting Results & Voting Rights Announcements	2025-07-02	English
Nyxoah - Second ESM 2025 - Notarial deed - FR (signed).pdf AGM Information	2025-07-02	French
FORM 6-K Regulatory Filings	2025-06-27	English
2025 06 27 - Press release - Number of shares (ENG).pdf Declaration of Voting Results & Voting Rights Announcements	2025-06-27	English
2025 06 27 - Press release - Number of shares (FR).pdf Declaration of Voting Results & Voting Rights Announcements	2025-06-27	French
FORM 6-K Regulatory Filings	2025-06-14	English
DOC 24 - Nyxoah - Second ESM 2025 - Proxy form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-06-13	French
DOC 23 - Nyxoah - Second ESM 2025 - Attendance notification form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-06-13	French
DOC 25 - Nyxoah - Second ESM 2025 - Form for voting by mail - ENG FR.pdf Proxy Solicitation & Information Statement	2025-06-13	French
DOC 21 - Nyxoah - Second ESM 2025 convening notice - PR (ENG).pdf AGM Information	2025-06-13	English
DOC 22 - Nyxoah - Second ESM 2025 convening notice - PR (FR).pdf AGM Information	2025-06-13	French
Nyxoah - ASM ESM 2025 - Resolutions - ENG.pdf Declaration of Voting Results & Voting Rights Announcements	2025-06-11	English
Nyxoah - ASM ESM 2025 - Notarial deed - FR (signed).pdf AGM Information	2025-06-11	French
Nyxoah - ASM ESM 2025 - Resolutions - ENG.pdf Declaration of Voting Results & Voting Rights Announcements	2025-06-11	English
Nyxoah - ASM ESM 2025 - Notarial deed - FR (signed).pdf AGM Information	2025-06-11	French
FORM 6-K Regulatory Filings	2025-05-30	English
2025 05 30 PR Transparency notifications 2025 05 (Vestal Point) (ENG).pdf Declaration of Voting Results & Voting Rights Announcements	2025-05-30	English
2025 05 30 PR Transparency notifications 2025 05 (Vestal Point) (FR).pdf Major Shareholding Notification	2025-05-30	French
FORM 6-K Regulatory Filings	2025-05-27	English
2025 05 23 - Press release - Number of shares (ENG).pdf Declaration of Voting Results & Voting Rights Announcements	2025-05-23	English
2025 05 23 - Press release - Number of shares (FR).pdf Declaration of Voting Results & Voting Rights Announcements	2025-05-23	French
Major Shareholding Notification 2025 Major Shareholding Notification	2025-05-15	English
FORM 6-K Regulatory Filings	2025-05-14	English
Nyxoah Reports First Quarter Financial and Operating Results Earnings Release Q1 2025	2025-05-14	English
Q1 2025 financial report (Euronext) (ENG) - FINAL.pdf Interim / Quarterly Report Q1 2025	2025-05-14	English
Q1 2025 financial report (Euronext) (FR) - FINAL.pdf Interim / Quarterly Report Q1 2025	2025-05-14	French
ENGLISH_Q1 2025 Earnings PR_V3.pdf Interim / Quarterly Report Q1 2025	2025-05-14	English
FRENCH_Q1 2025 Earnings PR_V3.pdf Interim / Quarterly Report Q1 2025	2025-05-14	French
FORM 6-K Regulatory Filings	2025-05-09	English
2025 05 09 PR Transparency notification 2025 05 (FMR LLC) (ENG).pdf Major Shareholding Notification	2025-05-09	English
2025 05 09 PR Transparency notification 2025 05 (FMR LLC) (FR).pdf Major Shareholding Notification	2025-05-09	French
FORM 6-K Regulatory Filings	2025-05-09	English
DOC 13 - Statutory management report 2024 - ENG.pdf Annual Report FY 2024	2025-05-09	English
DOC 15 - Auditor report - Statutory annual accounts (FR).pdf Audit Report / Information FY 2024	2025-05-09	French
DOC 14 - Statutory management report 2024 - FR.pdf Management Reports FY 2023	2025-05-09	French
DOC 03 - Nyxoah - ASM 2025 - Attendance notification form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-05-09	French
DOC 12 - Statutory annual accounts (FR).PDF Annual Report FY 2024	2025-05-09	French
DOC 07 - Nyxoah - ESM 2025 - Proxy form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-05-09	French
DOC 16 - Nyxoah Remuneration policy (submitted to ASM for approval).pdf Remuneration Information	2025-05-09	English
DOC 04 - Nyxoah - ASM 2025 - Proxy form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-05-09	French
DOC 08 - Nyxoah - ESM 2025 - Form for voting by mail - ENG FR.pdf Proxy Solicitation & Information Statement	2025-05-09	French
DOC 11 - Statutory annual accounts (ENG).PDF Annual Report FY 2024	2025-05-09	English
DOC 05 - Nyxoah - ASM 2025 - Form for voting by mail - ENG FR.pdf AGM Information	2025-05-09	French
DOC 06 - Nyxoah - ESM 2025 - Attendance notification form - ENG FR.pdf Proxy Solicitation & Information Statement	2025-05-09	French
DOC 01 - Nyxoah - ASM ESM 2025 convening notice - PR (ENG).pdf AGM Information	2025-05-09	English
DOC 02 - Nyxoah - ASM ESM 2025 convening notice - PR (FR).pdf AGM Information	2025-05-09	French
DOC 01 - Nyxoah - ASM ESM 2025 convening notice - PR (ENG).pdf AGM Information	2025-05-09	English
DOC 02 - Nyxoah - ASM ESM 2025 convening notice - PR (FR).pdf AGM Information	2025-05-09	French
FORM 6-K Regulatory Filings	2025-04-16	English
ATM PR - ENG - FINAL.pdf Share Issue/Capital Change	2025-04-16	English
ATM PR - FR - FINAL.pdf Share Issue/Capital Change	2025-04-16	French
FORM 6-K Regulatory Filings	2025-04-08	English
Nyxoah Provides Update on FDA Approvable Letter for Genio System Regulatory Filings	2025-04-08	English
Regulatory Filings 2025 Regulatory Filings	2025-04-02	English
Regulatory Filings 2025 Regulatory Filings	2025-03-28	English
Regulatory Filings 2025 Regulatory Filings	2025-03-26	English
FORM 6-K Regulatory Filings	2025-03-26	English
FDA Issues Nyxoah an Approvable Letter for its Genio System Regulatory Filings	2025-03-26	English
ENGLISH_FDA Approvable Press Release.pdf Regulatory Filings	2025-03-26	English
FRENCH_FDA Approvable Press Release.pdf Regulatory Filings	2025-03-26	French
F-3 Regulatory Filings	2025-03-20	English
FORM S-8 Regulatory Filings	2025-03-20	English
20-F Annual Report FY 2024	2025-03-20	English
252679_Nyxoah Annual report 2024_ENG_full_v7 (FINAL).pdf Annual Report FY 2024	2025-03-20	English
252679_Nyxoah Annual report 2024_FR_full_v8 (FINAL).pdf Annual Report FY 2024	2025-03-20	French
nyxoah-2024-12-31-0-fr.xbri Annual Report FY 2024	2025-03-20	French
nyxoah-2024-12-31-0-fr.xhtml Annual Report FY 2024	2025-03-20	French
252679_Nyxoah Annual report 2024_ENG_full_v7 (FINAL).pdf Management Reports	2025-03-20	English
252679_Nyxoah Annual report 2024_FR_full_v8 (FINAL).pdf Annual Report FY 2024	2025-03-20	French
nyxoah-2024-12-31-0-fr.xhtml Annual Report FY 2024	2025-03-20	French
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Earnings Release FY 2024	2025-03-14	English
FORM 6-K Regulatory Filings	2025-03-13	English
ENGLISH_Q4 2024 Earnings PR_FINAL.pdf Earnings Release Q4 2024	2025-03-13	English
FRENCH Q4 2024 Earnings PR_FINAL.pdf Earnings Release Q4 2024	2025-03-13	French
ENGLISH_Q4 2024 Earnings PR_FINAL.pdf Earnings Release Q4 2024	2025-03-13	English
FRENCH Q4 2024 Earnings PR_FINAL.pdf Earnings Release Q4 2024	2025-03-13	French
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results Earnings Release FY 2024	2025-03-13	English
Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Middle East Regulatory Filings	2025-02-20	English
Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Middle East Regulatory Filings	2025-02-19	English
Major Shareholding Notification 2025 Major Shareholding Notification	2025-02-14	English
2025 01 20 PR Transparency notification 2025 01 (BlackRock) (ENG).pdf Major Shareholding Notification	2025-01-20	English
2025 01 20 PR Transparency notification 2025 01 (BlackRock) (FR).pdf Major Shareholding Notification	2025-01-20	French
2025 01 20 PR Transparency notification 2025 01 (BlackRock) (ENG).pdf Major Shareholding Notification	2025-01-20	English
2025 01 20 PR Transparency notification 2025 01 (BlackRock) (FR).pdf Major Shareholding Notification	2025-01-20	French
FORM 6-K Regulatory Filings	2025-01-02	English